Comparison of the postoperative analgesic effects of paracetamol–codeine phosphate and naproxen sodium–codeine phosphate for lumbar disk surgery  by Polat, Reyhan et al.
Kaohsiung Journal of Medical Sciences (2015) 31, 468e472Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.kjms-onl ine.comORIGINAL ARTICLEComparison of the postoperative analgesic effects
of paracetamolecodeine phosphate and naproxen
sodiumecodeine phosphate for lumbar disk
surgery
Reyhan Polat a,*, Kevser Peker a, C¸igdem Topc¸u Gu¨lo¨ksu¨z b, Julide Ergil a,
Taylan Akkaya aa Department of Anesthesiology, Diskapi Yildirim Beyazit Research and Training Hospital,
Ministry of Health, Diskapi, Ankara, Turkey
b Department of Statistics, Science Faculty, Bartin University, Bartin, TurkeyReceived 10 April 2015; accepted 29 June 2015
Available online 6 August 2015KEYWORDS
Analgesics;
Lumbar disk surgery;
Naproxen sodium;
Nonnarcotic
analgesics;
ParacetamolConflicts of interest: All authors d
* Corresponding author. Zirvekent 2
E-mail address: reyhanp9@gmail.c
http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2015, KaohsiuAbstract The aim of this study was to compared the efficacy of paracetamolecodeine phos-
phate and naproxen sodiumecodeine phosphate on postoperative pain and tramadol consump-
tion during the first 24 hours after a lumbar disk surgery. After Ethics Committee approval and
informed consent had been obtained, 64 patients were allocated into three groups. Patients
received oral paracetamolecodeine (300 mg þ 30 mg; Group P), naproxen sodiumecodeine
(550 mg þ 30 mg; Group N), or placebo tablets (Group C) 30 minutes prior to induction of anes-
thesia. Patient-controlled analgesia was supplied postoperatively using tramadol. Pain inten-
sity, tramadol consumption, and side effects were recorded every 1 hour, 2 hours, 6 hours,
12 hours, and 24 hours after surgery. Whole study period pain intensity (visual analogue scale
scores) was lower in Group P (p Z 0.007) and Group N (p Z 0.001), compared with Group C,
however, there was no statistically significant difference between Group P and Group N
regarding pain intensity (p > 0.05). Tramadol consumption was lower in Group P and Group
N, compared with Group C (p < 0.001), and in turn the lowest incidence of tramadol consump-
tion was detected in Group P compared with Group N (p < 0.001) and Group C (p < 0.001). Side
effects were similar between the groups. Preemptive administration of paracetamolecodeine
and naproxen sodiumecodeine combination significantly reduced tramadol consumption and
provided more effective analgesia compared with placebo. The paracetamolecodeine combi-
nation was superior to naproxen sodiumecodeine with regard to tramadol consumption.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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Paracetamolecodeine and naproxen sodiumecodeine 469IntroductionAfter surgical intervention, 20e40% of patients report
moderate pain, and 50e70% of patients experience severe
pain. Effective postoperative pain control decreases post-
operative pain-related complications and improves patient
outcome [1]. Systemic opioids are regarded as the gold
standard for the relief of postoperative pain, however,
their use is limited by dose-related side effects [2]. To
overcome this problem, the adjunctive administration of
analgesics that act via different mechanisms during the
preoperative period as a preemptive analgesia is recom-
mended for effective postoperative pain control. Preemp-
tive analgesia reduces peripheral sensitization before
noxious stimuli occur by interrupting the noxious periop-
erative inputs transmission to the spinal cord. Preventing
central sensitization reduces pain and analgesic re-
quirements and analgesic-releated side effects [3].
The reduced doses of two (or more) drugs from different
classes given together can provide adequate pain relief,
acting via different targets while reducing dose-dependent
adverse events [4]. For example, nonsteroidal anti-
inflammatory drugs (NSAIDs) and paracetamol are periph-
erally acting analgesics, whereas codeine is a centrally
acting opioid. Used together, these drugs can have additive
analgesic effects [5]. Several studies have shown that the
combination of an opioid, either NSAIDs or paracetamol,
reduces the postoperative opioid requirement and de-
creases the incidence of opioid-induced side effects [6,7].
However, in studies investigating the effect of a combina-
tion of paracetamol and intravenous morphine as a patient-
controlled analgesia (PCA), the results are conflicting
regarding the opioid-sparing effect of this drug combination
[8,9]. NSAIDs also have numerous contraindications and side
effects and consequently cannot be used in >25% of post-
operative patients [10,11]; however, paracetamol has very
few contraindications and is relatively free from side ef-
fects at clinical doses [12]. Codeine is commercially avail-
able in combination with peripherally acting analgesics
such as naproxen sodium or acetaminophen.
To our knowledge, no previous study has assessed the
effects of naproxen sodiumecodeine or para-
cetamolecodeine orally administered prior to surgery in
patients undergoing lumbar disk surgery. Thus, this
controlled clinical trial was designed to investigate the
analgesic efficacy and opioid-sparing effect of a single dose
of oral naproxen sodiumecodeine or paracetamolecodeine
on postoperative pain in adult patients undergoing lumbar
discectomy.
Materials and methods
This study was approved by the Diskapi Yildirim Beyazit
Education and Research Hospital ethics committee (2014/
20), conducted in accordance with the Declaration of Hel-
sinki, and was registered at http://clinicaltrials.gov
(registration number NCT02255955). The study was per-
formed at Diskapi Yildirim Beyazit Education and Research
Hospital between October and December 2014. We enrolled
64 consecutive patients, aged 18e65 years and assessed as
American Society of Anesthesiologists Physical Status IeII,who underwent general anesthesia for an elective single-
level unilateral microsurgical lumbar discectomy. Written
informed consent was obtained from all patients prior to
randomization. The exclusion criteria were known allergies
to any of the drugs used in this study, peptic ulcer disease,
hepatic and renal dysfunction, emergency surgery, or
inability to provide informed consent (e.g., mental disor-
ders). All patients were instructed regarding the use of PCA
pumps [Abbott, Abbott Provider, Pain Manager II (APM II)
Single-Channel PCA; Chicago, IL, USA].
The patients were randomly assigned into three groups
by computer-generated random numbers. Thirty minutes
prior to the surgery, the naproxen sodiumecodeine group
(Group N, n Z 20) received an oral naproxen
sodium þ codeine phosphate (550 mg þ 30 mg) tablet
(Apranax Plus Tablet; Abdi _Ibrahim, Istanbul, Turkey), the
paracetamolecodeine group (Group P, n Z 20) received a
paracetamol þ codeine phosphate (300 mg þ 30 mg) tablet
(Geralgine Plus Tablet; Mu¨nir S‚ahin, Istanbul, Turkey), and
the control group (Group C, n Z 20) received an oral pla-
cebo. The study drugs were administered by a nurse, and
the postoperative data were collected by a blinded
anesthesiologist.
In the operating room, after routine monitoring, anes-
thesia was induced with propofol (1.5e2 mg/kg), rocuro-
nium (0.6 mg/kg), and fentanyl (0.1 mg/kg), and maintained
with sevoflurane (1e1.5 mean alveolar concentration) in
oxygen/air (fraction of inspired oxygen of 0.40) and remi-
fentanil infusion (0.05e0.1 mg/kg/min). Residual muscle
relaxation was reversed with atropine (0.01 mg/kg) and
neostigmine (0.02 mg/kg) at the end of the surgery. All
patients received tramadol using a PCA pump for 24 hours
postoperatively. The PCA solution was prepared with
500 mg tramadol in 100 mL normal saline. The PCA was set
to administer a bolus dose of 20 mg on demand with a
lockout period of 10 minutes and no back ground infusion.
Because a 10-minute lockout interval was set with the PCA
pump if the patient’s pain score was >4, tramadol (1 mg/
kg) was administered intravenously.
The patients were assessed for pain at 0 hours, 1 hour, 2
hours, 6 hours, 12 hours, and 24 hours postoperatively using
a visual analogue scale (100-mm linear scale, where 0Z no
pain, 100 mm Z worst pain imaginable). Sedation was
evaluated on the basis of the Ramsay score [13]. Total
tramadol consumption, Ramsay score, postoperative side
effects such as constipation, drowsiness, dizziness, nausea,
and vomiting, defined by a scale where 0 Z absent and
1 Z present, were recorded each time the pain intensity
was evaluated. The patients did not receive antiemetic
prophylaxis. Postoperative nausea and vomiting were
treated with 8 mg ondansetron.
Based on a previous study [3] and the assumption that a
difference of 20 U in postoperative pain scores on the visual
analogue scale is clinically relevant, we carefully defined
the effect size to be 2, with an estimated standard devia-
tion of 2. By setting a Z 0.05 and power Z 0.9, we
calculated a sample size of 18 patients/group. To
compensate for possible dropouts, 21 patients/group were
included.
The statistical analyses were performed using SPSS 11.5
software (SPSS Inc., Chicago, IL, USA) and R Language
(3.1.2). The normality of the distribution was assessed using
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Figure 1. Pain intensity at each of the indicated time
intervals (mean  SD). Consecutive visual analogue scale
measurements for the whole study period were analyzed by
Package ‘nparLD’. Group P and group N versus group C, *p <
0.05; group P versus group N, **p > 0.05 for 24 hours.
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Figure 2. Cumulative tramadol consumption in groups during
the postoperative 24 hours (mean  standard deviation). Group
P and N versus Group C, *p < 0.001; Group P versus Group N,
**p < 0.001.
470 R. Polat et al.the ShapiroeWilk test. The nonparametric data (body mass
index, age, total drug consumption, and duration of sur-
gery) were analyzed using the ManneWhitney U test, and
one-way analysis of variance was used for the parametric
data (duration of anesthesia). The categorical data (sex,
American Society of Anesthesiologists) were compared
using Fisher’s exact test. Nonparametric longitudinal data
analyses were performed by nparLD module at R software
package that is an open source statistical software (http://
www.R-project.org). The results are given as the
mean  standard deviation and count (percentage). A p
value < 0.05 was considered a statistically significant
difference.
Results
Sixty-four patients were enrolled in the study. Four patients
were excluded during the study. Two patients from Group P,
one patient from Group N, and one patient from Group C
were excluded owing to a technical failure of the PCA
pump. The groups were similar with respect to age, sex,
body mass index, and the durations of anesthesia and sur-
gery (Table 1).
When the whole study period was analyzed, the pain
intensity was lower in Groups P (p Z 0.007) and N
(pZ 0.001) compared with Group C, however, there was no
statistically significant difference between Groups P and N
(p > 0.05; Figure 1).
When tramadol consumption was evaluated, tramadol
consumption was lower in Groups P (86  39.52 mg) and N
(138  52.28 mg) compared with Group C (250  31.46 mg)
(p < 0.001). Furthermore, the tramadol consumption level
was lower in Group P than in Group N (p < 0.001; Figure 2).
Four (20%) patients in Group P, five (25%) patients in
Group N, and five (25%) patients in Group C complained of
nausea and vomiting. The hemodynamic values, Ramsey
sedation scores, and postoperative nausea and vomiting for
all three groups were similar (p > 0.05 for all of the com-
parisons). There was no adverse aspiration event. No pa-
tient complained of constipation during the study period.
No patient complained of dizziness or drowsiness.
Discussion
In this study, we evaluated the efficacy of preemptive para-
cetamolecodeine (300 mg þ 30 mg) and naproxen
sodiumecodeine (500mgþ30mg) inpatientswhounderwent
single level unilateral microdiscectomy. We demonstrated
that preemptive administration of paracetamolecodeine orTable 1 Patient characteristics.
Paracetamolecodeine (n Z 20) N
Age (y) 44.95  10.08
Female sex 10 (50)
Body mass index (kg/m2) 25.80  4
Duration of anesthesia (min) 93.95  10.84
Duration of surgery (min) 81.45  11.12
Data are presented as mean  SD or n (%).
SD Z standard deviation.naproxen sodiumecodeine significantly reduced tramadol
consumption and provided more effective analgesia
compared with placebo. The paracetamolecodeine combi-
nationwas superior to naproxen sodiumecodeinewith regard
to reducing tramadol consumption. Preemptive NSAIDs and
paracetamol have been widely used as multimodal analgesia
to treat postoperative pain [14,15].
Paracetamol has both central inhibitor action on cyclo-
oxygenases and interaction with the serotonergic systemaproxen sodiumecodeine (n Z 20) Control (n Z 20) p
45.05  9.68 43.10  10.82 0.910
9 (45) 8 (40) 0.627
27.06  2.82 26.25  2.99 0.594
91.75  8.94 89  10.12 0.3
77.80  7.98 73.75  8.99 0.079
Paracetamolecodeine and naproxen sodiumecodeine 471[16]. It may be used alone or in combined analgesic regi-
mens for the PCA device treatment of mild and moderate
postoperative pain [8,17]. Seymour et al [18] demonstrated
that 1 g paracetamol was safe and effective at providing
significant pain relief after third molar surgery. However,
the efficacy of paracetamol in postoperative reduction of
opioid consumption after major surgery remains contro-
versial. In a study by Tunali et al [6], oral administration of
1 g paracetamol every 6 hours for 24 hours following lumbar
disk surgery was not effective at reducing pain scores or
morphine consumption compared with placebo; similar re-
sults were reported by Uzun et al [14]. A para-
cetamoleopioid combination is recommended for pain not
controlled by paracetamol alone. Tramadol exhibits both
mild m-opioid receptor binding and norepinephrine and se-
rotonin reuptake inhibition. A study conducted by Emir et al
[19] demonstrated that a preemptive combination of
0.75 mg/kg tramadol and 1 g of paracetamol was effective
at reducing postoperative pain intensity in patients who
underwent spinal vertebral surgery despite the fact that
only a low postoperative dose of infused tramadol was
used.
Codeine is a prodrug with well-known analgesic efficacy,
and it is frequently used in pain management. It is
metabolized to its active form, morphine, by the liver. The
recently published Cochrane review that includes 14
clinical trials states that combining paracetamol
(600e1000 mg) with codeine (30e60 mg) provides clinically
useful levels of pain relief in approximately 50% of patients
with moderate to severe postoperative pain and that this
combination prolonged the duration of analgesia compared
with paracetamol alone [20]. In this work, we found that
paracetamolecodeine (300 mg þ 30 mg) reduced the pain
intensity and also reduced tramadol consumption by
approximately 65% when used as a supplemental analgesic
with a tramadol PCA pump. In our study, we were able to
provide effective analgesia with a lower dose of paraceta-
mol than was used in the study by Emir et al [19]. These
differences may be explained by the difference in the type
of surgery; spinal vertebral surgery is more invasive than
disk surgery.
NSAIDs reduce peripheral nociception by reducing the
inflammatory response to surgical trauma and modulating
the central response to painful stimuli by inhibiting pros-
taglandin synthesis in the spinal cord. The analgesic effi-
cacy of NSAIDs for postoperative pain has been investigated
in many studies, and their analgesic efficacy is considered
to be as high as that of opioids [6,11,12].
Naproxen sodium, a peripherally acting anti-inflammatory
drug, is used to treat various painful conditions, including
postoperative pain [7,21]. However, in the literature we
found only a small number of studies that had investigated
theanalgesic efficacyofanaproxenecodeinecombinationon
postoperative pain. For this reason, we compared naproxen
sodiumecodeine and paracetamolecodeine in patients un-
dergoing unilateral single level lumbar microdiscectomy.
The analgesic efficacy of naproxenecodeine may be
attributable to the prevention of sensitization in peripheral
and central pathways. Forbes et al [22] compared the ef-
fect of naproxen sodiumecodeine, naproxen sodium, and
placebo on postoperative pain 12 hours after oral surgery.
They demonstrated that the naproxen sodiumecodeinecombination was superior to placebo or naproxen sodium
alone. In another study, Bali et al [23] compared the effi-
cacy of preemptive 550 mg naproxen sodium and naproxen
sodiumecodeine (550 mg þ 30 mg) in patients undergoing
arthroscopic meniscectomy, and they also found that the
combination of naproxen sodiumecodeine provided more
effective analgesia and lower meperidine consumption
than naproxen sodium alone. Similarly, in our study, we
found that naproxen sodiumecodeine reduced the pain
intensity and also reduced tramadol consumption by almost
50% compared with placebo when used as a supplemental
analgesic to tramadol PCA. The higher efficacy of naprox-
enecodeine compared with placebo may be related to the
well-known analgesic efficacy of codeine.
Codeine, a centrally acting opioid, can have additive
analgesic effects when combined with peripherally acting
agents. In a review by Derry et al [17], which included 35
clinical trials comparing codeine (60e90 mg) with placebo in
postoperative pain management, codeine alone at 60 mg
provided better analgesia than placebo. However, this
analgesia was not as effective as when it was used in com-
bination with paracetamol and NSAIDs. We also found that
both naproxen sodiumecodeine and paracetamolecodeine
combinations provided effective analgesia.
The effective dose of codeine phosphate is 30e60 mg; at
doses >60 mg, there is a significant increase in the inci-
dence of side effects, such as constipation, nausea, and
respiratory depression. In our study, we did not encounter
constipation or respiratory depression, perhaps because of
the codeine dose that was used. We propose that a com-
bination of tramadol and supplemental analgesics con-
taining codeine might reduce the amount of systemic
tramadol consumption and therefore the incidence of side
effects, such as sedation, nausea, and vomiting.
Although we were not able to demonstrate a difference
in the pain scores between the two treatment groups, we
did find a significant difference in the amount of tramadol
consumption. The incidence of postoperative adverse ef-
fects was similar between the treatment groups.Conclusion
Both preemptive oral naproxen sodiumecodeine and para-
cetamolecodeine combinations provided better pain relief
than the placebo following lumbar disk surgery. Although
both drug combinations also reduced the amount of post-
operative tramadol consumption, paracetamolecodeine
was more effective than naproxen sodiumecodeine in this
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